Adam Lenkowsky

BMY

Adam Lenkowsky serves as EVP, Chief Commercial Officer at Bristol-Myers Squibb Company (BMY). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$651.5K

Net Position

Net Seller

$651.5K

Companies Traded

BMY

Active Period

Jun 2023 – Mar 2025

3 total trades

Most Recent

Sell BMY

Mar 12, 2025 · $382.8K

Adam Lenkowsky's Insider Trading at Bristol-Myers Squibb Company (BMY)

Buys

0 · $0.00

Sells

3 · $651.5K

Total Shares Bought

Total Shares Sold

10,939

BMY Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Mar 12, 2025↗	Sell	6,065	$63.11	$382.8K
Mar 10, 2024↗	Sell	4,323	$53.79	$232.5K
Jun 3, 2023↗	Sell	551	$65.66	$36.2K

Related Insiders

Benjamin Hickey

President, RayzeBio Org.

BMYSell · Feb 1, 2026

Gregory Scott Meyers

EVP, Chief Digital & Tech Off.

BMYSell · Feb 1, 2026

Karin Shanahan

EVP, Chief Supply Chain & Ops

BMYSell · Nov 1, 2025

BOERNER CHRISTOPHER S.

Chief Executive Officer

BMYSell · Nov 1, 2025

Cari Gallman

EVP, General Counsel

BMYSell · Oct 2, 2025

David Elkins V

EVP, Chief Financial Officer

BMYSell · Sep 2, 2025

Bartie Wendy Short

EVP, Corporate Affairs

BMYSell · Sep 1, 2025

Samit Hirawat

EVP,Chief Med.Offr.,Drug Dev.

BMYBuy · Apr 25, 2025

Explore More Insider Trading Data

BMY Insider Trading Activity

View all insider trades at Bristol-Myers Squibb Company

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity